Gros David-Alexandre C Insider Trades

Insider Trading History

Track insider trading activity for Gros David-Alexandre C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $2.41M 600,000 shares
Last Trade
Jan 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 600,000 shares
$4.04
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $4.08M 1,015,743 shares
Last Trade
Nov 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.13M 1,015,743 shares
$4.07
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $2.08M 517,454 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.52M 517,454 shares
$2.94
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $1.54M 383,299 shares
Last Trade
May 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$882k 383,299 shares
$2.30
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $1.21M 300,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.53M 453,600 shares
$3.38
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $434k 108,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 108,000 shares
$3.97
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $36.2k 9,000 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.96k 2,000 shares
$4.48
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $28.1k 7,000 shares
Last Trade
Aug 17, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.8k 4,000 shares
$6.21
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $12.1k 3,000 shares
Last Trade
Jun 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24k 3,000 shares
$8.01
$4.02
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $73.5k 18,278 shares
Last Trade
Sep 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.02
Neurocrine Biosciences
Neurocrine Biosciences NBIX
President & COO
Holding Value $4.3M 25,000 shares
Last Trade
Feb 06, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 25,000 shares
$43.24
$172.05
Neurocrine Biosciences
Neurocrine Biosciences NBIX
President & COO
Holding Value $60.2M 350,000 shares
Last Trade
Feb 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.9M 350,000 shares
$42.55
$172.05
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $6.98M 25,000 shares
Last Trade
Dec 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 25,000 shares
$42.22
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $279k 1,000 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.5k 900 shares
$62.75
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $27.9k 100 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.27k 100 shares
$62.74
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $4.19M 15,012 shares
Last Trade
Dec 18, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 15,012 shares
$88.95
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $39.1M 140,000 shares
Last Trade
Jun 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.2M 140,000 shares
$129.97
$279.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up